Request Free Sample ×
US Inverter Market Research Report - Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Inverter Market

ID: MRFR/EnP/53744-HCR
200 Pages
Chitranshi Jaiswal
Last Updated: April 09, 2026

US Inverter Market Research Report By Type (Solar inverter, Vehicle inverter, Others), By Output Power Rating (Below 10 kW, 10-50 kW, 51-100 kW, Above 100 kW), By End User (Residential, Photovoltaic (PV) Plants, Automotive, Others), By Connection Type (Standalone, Grid-tied), By Output Voltage (100-300 V, 301-500 V, Above 500 V) and By Sales Channel (Direct, Indirect) – United States Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Inverter Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Output Power Rating (USD Million)
  49.     4.1.1 Below 10 kW
  50.     4.1.2 10-50 kW
  51.     4.1.3 51-100 kW
  52.     4.1.4 Above 100 kW
  53.   4.2 Pharmaceutical, BY End User (USD Million)
  54.     4.2.1 Residential
  55.     4.2.2 Photovoltaic (PV) Plants
  56.     4.2.3 Automotive
  57.     4.2.4 Others
  58.   4.3 Pharmaceutical, BY Type (USD Million)
  59.     4.3.1 Solar inverter
  60.     4.3.2 Vehicle inverter
  61.     4.3.3 Others
  62.   4.4 Pharmaceutical, BY Output Voltage (USD Million)
  63.     4.4.1 100-300 V
  64.     4.4.2 301-500 V
  65.     4.4.3 Above 500 V
  66.   4.5 Pharmaceutical, BY Connection Type (USD Million)
  67.     4.5.1 Standalone
  68.     4.5.2 Grid-tied
  69.   4.6 Pharmaceutical, BY Sales Channel (USD Million)
  70.     4.6.1 Direct
  71.     4.6.2 Indirect
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Pharmaceutical
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 SMA Solar Technology AG (DE)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 Fronius International GmbH (AT)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 SolarEdge Technologies Inc (IL)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 Enphase Energy Inc (US)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 ABB Ltd (CH)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Schneider Electric SE (FR)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 TMEIC Corporation (JP)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 Huawei Technologies Co Ltd (CN)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.     5.2.9 Victron Energy B.V. (NL)
  137.       5.2.9.1 Financial Overview
  138.       5.2.9.2 Products Offered
  139.       5.2.9.3 Key Developments
  140.       5.2.9.4 SWOT Analysis
  141.       5.2.9.5 Key Strategies
  142.   5.3 Appendix
  143.     5.3.1 References
  144.     5.3.2 Related Reports
  145. 6 LIST OF FIGURES
  146.   6.1 MARKET SYNOPSIS
  147.   6.2 US MARKET ANALYSIS BY OUTPUT POWER RATING
  148.   6.3 US MARKET ANALYSIS BY END USER
  149.   6.4 US MARKET ANALYSIS BY TYPE
  150.   6.5 US MARKET ANALYSIS BY OUTPUT VOLTAGE
  151.   6.6 US MARKET ANALYSIS BY CONNECTION TYPE
  152.   6.7 US MARKET ANALYSIS BY SALES CHANNEL
  153.   6.8 KEY BUYING CRITERIA OF PHARMACEUTICAL
  154.   6.9 RESEARCH PROCESS OF MRFR
  155.   6.10 DRO ANALYSIS OF PHARMACEUTICAL
  156.   6.11 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  157.   6.12 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  158.   6.13 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  159.   6.14 PHARMACEUTICAL, BY OUTPUT POWER RATING, 2024 (% SHARE)
  160.   6.15 PHARMACEUTICAL, BY OUTPUT POWER RATING, 2024 TO 2035 (USD Million)
  161.   6.16 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
  162.   6.17 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
  163.   6.18 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
  164.   6.19 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
  165.   6.20 PHARMACEUTICAL, BY OUTPUT VOLTAGE, 2024 (% SHARE)
  166.   6.21 PHARMACEUTICAL, BY OUTPUT VOLTAGE, 2024 TO 2035 (USD Million)
  167.   6.22 PHARMACEUTICAL, BY CONNECTION TYPE, 2024 (% SHARE)
  168.   6.23 PHARMACEUTICAL, BY CONNECTION TYPE, 2024 TO 2035 (USD Million)
  169.   6.24 PHARMACEUTICAL, BY SALES CHANNEL, 2024 (% SHARE)
  170.   6.25 PHARMACEUTICAL, BY SALES CHANNEL, 2024 TO 2035 (USD Million)
  171.   6.26 BENCHMARKING OF MAJOR COMPETITORS
  172. 7 LIST OF TABLES
  173.   7.1 LIST OF ASSUMPTIONS
  174.     7.1.1
  175.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  176.     7.2.1 BY OUTPUT POWER RATING, 2025-2035 (USD Million)
  177.     7.2.2 BY END USER, 2025-2035 (USD Million)
  178.     7.2.3 BY TYPE, 2025-2035 (USD Million)
  179.     7.2.4 BY OUTPUT VOLTAGE, 2025-2035 (USD Million)
  180.     7.2.5 BY CONNECTION TYPE, 2025-2035 (USD Million)
  181.     7.2.6 BY SALES CHANNEL, 2025-2035 (USD Million)
  182.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  183.     7.3.1
  184.   7.4 ACQUISITION/PARTNERSHIP
  185.     7.4.1

US Pharmaceutical Market Segmentation

Pharmaceutical By Output Power Rating (USD Million, 2025-2035)

  • Below 10 kW
  • 10-50 kW
  • 51-100 kW
  • Above 100 kW

Pharmaceutical By End User (USD Million, 2025-2035)

  • Residential
  • Photovoltaic (PV) Plants
  • Automotive
  • Others

Pharmaceutical By Type (USD Million, 2025-2035)

  • Solar inverter
  • Vehicle inverter
  • Others

Pharmaceutical By Output Voltage (USD Million, 2025-2035)

  • 100-300 V
  • 301-500 V
  • Above 500 V

Pharmaceutical By Connection Type (USD Million, 2025-2035)

  • Standalone
  • Grid-tied

Pharmaceutical By Sales Channel (USD Million, 2025-2035)

  • Direct
  • Indirect

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓